Bank of New York Mellon’s Medifast MED Stock Holding History

Bank of New York Mellon’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-34,291	Closed	-$349K	–	4383
2026 Q1	$349K	Sell	34,291 -2,965	-8%	-$32K	﹤0.01%	3781
2025 Q4	$398K	Sell	37,256 -14,855	-29%	-$178K	﹤0.01%	3726
2025 Q3	$712K	Buy	52,111 +2,064	+4%	+$28.8K	﹤0.01%	3401
2025 Q2	$703K	Buy	50,047 +1,250	+3%	+$16.4K	﹤0.01%	3324
2025 Q1	$658K	Sell	48,797 -7,521	-13%	-$113K	﹤0.01%	3305
2024 Q4	$992K	Sell	56,318 -2,406	-4%	-$44.6K	﹤0.01%	3171
2024 Q3	$1.12M	Sell	58,724 -15,527	-21%	-$299K	﹤0.01%	3079
2024 Q2	$1.62M	Sell	74,251 -37,837	-34%	-$1.01M	﹤0.01%	2915
2024 Q1	$4.3M	Sell	112,088 -88,999	-44%	-$4.31M	﹤0.01%	2397
2023 Q4	$13.5M	Buy	201,087 +6,718	+3%	+$468K	﹤0.01%	1813
2023 Q3	$14.5M	Buy	194,369 +4,005	+2%	+$355K	﹤0.01%	1723
2023 Q2	$17.5M	Buy	190,364 +4,629	+2%	+$412K	﹤0.01%	1621
2023 Q1	$19.3M	Sell	185,735 -10,571	-5%	-$1.17M	﹤0.01%	1563
2022 Q4	$22.6M	Buy	196,306 +20,664	+12%	+$2.41M	0.01%	1470
2022 Q3	$19M	Sell	175,642 -5,168	-3%	-$741K	﹤0.01%	1524
2022 Q2	$32.6M	Sell	180,810 -1,634	-0.9%	-$292K	0.01%	1244
2022 Q1	$31.2M	Buy	182,444 +359	+0.2%	+$67.7K	0.01%	1406
2021 Q4	$38.1M	Sell	182,085 -28,967	-14%	-$5.99M	0.01%	1334
2021 Q3	$40.7M	Sell	211,052 -5,966	-3%	-$1.47M	0.01%	1272
2021 Q2	$61.4M	Buy	217,018 +1,606	+0.7%	+$435K	0.01%	998
2021 Q1	$45.6M	Sell	215,412 -1,351	-0.6%	-$323K	0.01%	1169
2020 Q4	$42.6M	Sell	216,763 -11,012	-5%	-$1.95M	0.01%	1143
2020 Q3	$37.5M	Sell	227,775 -6,671	-3%	-$1.1M	0.01%	1077
2020 Q2	$32.5M	Sell	234,446 -3,705	-2%	-$340K	0.01%	1148
2020 Q1	$14.9M	Sell	238,151 -12,779	-5%	-$1.16M	﹤0.01%	1475
2019 Q4	$27.5M	Buy	250,930 +56,297	+29%	+$5.45M	0.01%	1384
2019 Q3	$20.2M	Buy	194,633 +8,290	+4%	+$891K	0.01%	1524
2019 Q2	$23.9M	Sell	186,343 -670	-0.4%	-$93.1K	0.01%	1456
2019 Q1	$23.9M	Sell	187,013 -8,484	-4%	-$1.08M	0.01%	1450
2018 Q4	$24.4M	Buy	195,497 +4,546	+2%	+$778K	0.01%	1344
2018 Q3	$42.3M	Buy	190,951 +16,737	+10%	+$3.39M	0.01%	1134
2018 Q2	$27.9M	Sell	174,214 -1,578	-0.9%	-$202K	0.01%	1394
2018 Q1	$16.4M	Sell	175,792 -2,223	-1%	-$166K	﹤0.01%	1704
2017 Q4	$12.4M	Sell	178,015 -20,589	-10%	-$1.37M	﹤0.01%	1884
2017 Q3	$11.8M	Sell	198,604 -17,495	-8%	-$871K	﹤0.01%	1905
2017 Q2	$8.96M	Sell	216,099 -2,279	-1%	-$99.1K	﹤0.01%	2030
2017 Q1	$9.69M	Buy	218,378 +3,975	+2%	+$171K	﹤0.01%	1992
2016 Q4	$8.93M	Buy	214,403 +58,114	+37%	+$2.34M	﹤0.01%	2013
2016 Q3	$5.91M	Buy	156,289 +11,314	+8%	+$406K	﹤0.01%	2153
2016 Q2	$4.82M	Sell	144,975 -20,542	-12%	-$663K	﹤0.01%	2229
2016 Q1	$5M	Sell	165,517 -4,958	-3%	-$145K	﹤0.01%	2181
2015 Q4	$5.18M	Sell	170,475 -750	-0.4%	-$22.3K	﹤0.01%	2193
2015 Q3	$4.6M	Sell	171,225 -23,803	-12%	-$693K	﹤0.01%	2278
2015 Q2	$6.3M	Sell	195,028 -388	-0.2%	-$12.3K	﹤0.01%	2220
2015 Q1	$5.86M	Sell	195,416 -9,332	-5%	-$296K	﹤0.01%	2230
2014 Q4	$6.87M	Buy	204,748 +2,330	+1%	+$72.6K	﹤0.01%	2136
2014 Q3	$6.64M	Buy	202,418 +6,721	+3%	+$206K	﹤0.01%	2138
2014 Q2	$5.95M	Sell	195,697 -24,313	-11%	-$758K	﹤0.01%	2228
2014 Q1	$6.4M	Sell	220,010 -42,381	-16%	-$1.14M	﹤0.01%	2178
2013 Q4	$6.86M	Sell	262,391 -10,831	-4%	-$278K	﹤0.01%	2101
2013 Q3	$7.35M	Buy	273,222 +846	+0.3%	+$22.6K	﹤0.01%	1996
2013 Q2	$7.02M	Buy	+272,376	New	+$7.15M	﹤0.01%	1991

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return

Commons Capital Needham, Massachusetts $143M AUM 30.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VFO

Virtus Family Office El Paso, Texas $126M AUM 23.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GLA

Great Lakes Advisors Chicago, Illinois $13.1B AUM 34.09% 1-Year Est. Return

SIM

SummerHaven Investment Management Stamford, Connecticut $187M AUM 70.61% 1-Year Est. Return

Bank of New York Mellon's MED Position: Q2 2026 in Review

Bank of New York Mellon sold out of Medifast (MED) in Q2 2026, closing a stake of 34,291 shares — an estimated $349K sold.

Bank of New York Mellon first reported a position in MED in Q2 2013 and held it in 52 quarters. The position peaked at $61.4M in Q2 2021. 51 funds tracked by Wall St. Rank hold MED as of Q2 2026.

Bank of New York Mellon reported no remaining Medifast position as of Q2 2026 after selling out during the quarter.
Bank of New York Mellon sold 34,291 Medifast shares in Q2 2026, an estimated $349K.
Bank of New York Mellon first reported a position in Medifast in Q2 2013 and held it in 52 quarters.
Bank of New York Mellon's Medifast position peaked at $61.4M in Q2 2021.
51 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.